MARKET

TYME

TYME

Tyme Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.490
+0.070
+4.93%
After Hours: 1.490 0 0.00% 16:16 10/23 EDT
OPEN
1.420
PREV CLOSE
1.420
HIGH
1.510
LOW
1.380
VOLUME
548.34K
TURNOVER
--
52 WEEK HIGH
4.642
52 WEEK LOW
0.9200
MARKET CAP
166.81M
P/E (TTM)
-5.2502
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TYME and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TYME News

  • Tyme Tech down 8% on $30M stock sales deal
  • seekingalpha.5d ago
  • Microcaps mostly among midday movers
  • Seeking Alpha - Article.5d ago
  • Tyme Technologies Filing Shows Registration For $30M Common Stock Offering
  • Benzinga.5d ago
  • TYME Presents Business Update and Announces Second Quarter Fiscal 2020 Conference Call and Preliminary Operational Results
  • GlobeNewswire.6d ago

More

Industry

Biotechnology & Medical Research
+0.09%
Pharmaceuticals & Medical Research
-0.25%

Hot Stocks

Name
Price
%Change

About TYME

Tyme Technologies, Inc. is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system. The Company’s lead clinical program, SM-88, is a first-in-class combination therapy in Phase II development for prostate cancer, and it is preparing to initiate an additional Phase II clinical trial for pancreatic cancer. The Company provides a novel compound for physicians to use in a treatment regimen for patients fighting six major cancers including breast, lung, prostate, gastric, esophageal and pancreatic cancers.
More

Webull offers Tyme Technologies Inc (TYME) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.